共 50 条
- [23] Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2450 - 2458
- [24] EFFECTS OF GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE ON THE CONCENTRATIONS OF INSULIN AND GLUCOSE IN SHEEP COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 1993, 105 (04): : 705 - 709
- [27] Glucagon-like peptide-1 accelerates the onset of insulin action on glucose disappearance in mice AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (06): : E1808 - E1814
- [28] Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans ACTA PHYSIOLOGICA SCANDINAVICA, 1997, 160 (04): : 413 - 422
- [29] Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 79 - 87
- [30] Long-term insulinotropic activity of glucagon-like peptide-1/polymer conjugate on islet microcapsules TISSUE ENGINEERING, 2004, 10 (11-12): : 1607 - 1616